Marshall Wace’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$73.6K Buy
+17,900
New +$86.7K ﹤0.01% 2936
2025
Q4
Sell
-56,588
Closed -$347K 3097
2025
Q3
$347K Sell
56,588
-11,258
-17% -$87.8K ﹤0.01% 2367
2025
Q2
$625K Buy
+67,846
New +$694K ﹤0.01% 2061
2024
Q3
Sell
-201,849
Closed -$2.19M 2618
2024
Q2
$2.19M Sell
201,849
-16,451
-8% -$202K ﹤0.01% 1324
2024
Q1
$3.06M Sell
218,300
-335,226
-61% -$4.36M ﹤0.01% 1190
2023
Q4
$5.83M Sell
553,526
-121,830
-18% -$1.09M 0.01% 861
2023
Q3
$6.17M Sell
675,356
-361,518
-35% -$3.24M 0.01% 794
2023
Q2
$7.54M Buy
1,036,874
+925,963
+835% +$7.99M 0.01% 859
2023
Q1
$938K Buy
+110,911
New +$1M ﹤0.01% 1848
2022
Q4
Sell
-186,874
Closed -$1.5M 3057
2022
Q3
$1.5M Buy
+186,874
New +$1.98M ﹤0.01% 2193
2022
Q2
Sell
-16,903
Closed -$190K 3530
2022
Q1
$190K Buy
+16,903
New +$144K ﹤0.01% 3116
2021
Q4
Sell
-255,537
Closed -$1.95M 3954
2021
Q3
$1.95M Sell
255,537
-232,882
-48% -$2.41M 0.01% 1574
2021
Q2
$6.18M Buy
488,419
+220,296
+82% +$2.42M 0.03% 718
2021
Q1
$3.48M Buy
+268,123
New +$2.47M 0.02% 1033

Other funds holding EOLS

Marshall Wace's EOLS Position: Q1 2026 in Review

Marshall Wace opened a new position in Evolus (EOLS) in Q1 2026: 17,900 shares worth $73.6K. The stake represents ﹤0.01% of the portfolio and ranks #2936 among its holdings. This is a return to the name: Marshall Wace previously reported a position in EOLS as recently as Q3 2025.

Marshall Wace first reported a position in EOLS in Q1 2021 and has held it in 14 quarters since. The position peaked at $7.54M in Q2 2023. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Marshall Wace held 17,900 shares of Evolus worth $73.6K as of Q1 2026.
  • Evolus was a new Marshall Wace position in Q1 2026.
  • Evolus made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2936 holding.
  • Marshall Wace first reported a position in Evolus in Q1 2021 and has held it in 14 quarters since.
  • Marshall Wace's Evolus position peaked at $7.54M in Q2 2023.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.